Chief Medical Officer
Dmitry joined Oxford Biomedica in July 2019 as a permanent member of the Senior Executive Team having previously worked for 10 months with the company as a consultant. He brings 15+ years of experience in clinical development within the pharmaceutical and biotechnology industry. He started his pharmaceutical career at GSK, then moving to Ono Pharmaceutical and later to Daiichi Sankyo where he spent over 7 years in cardiovascular and metabolic diseases. Before joining Oxford Biomedica, Dmitry spent 2 years working with Grunenthal GmbH in Germany, most recently as a Head of Development Strategy and Intelligence. He holds a medical doctor’s degree and specialisation in obstetrics and gynaecology as well as an MBA from Warwick Business School.